New uses for lithium and anticonvulsants

Area of Science:

• Psychiatry and Pharmacology
• Neuroscience and Mood Disorders

Background:

• Bipolar mood disorder is primarily treated with lithium and anticonvulsant medications.
• Emerging evidence suggests broader therapeutic applications for these established drugs.

Purpose of the Study:

• To review the literature on the antidepressant and augmenting effects of lithium, lamotrigine, and divalproex.
• To explore potential novel therapeutic uses for these medications beyond bipolar disorder treatment.

Main Methods:

• Literature review of clinical observations and open clinical trials.
• Analysis of reported antidepressant monotherapy and augmentation effects.
• Examination of case series and uncontrolled trials for additional indications.

Main Results:

• Lithium and lamotrigine demonstrate significant antidepressant effects when used as monotherapy.
• Lithium strongly augments antidepressant therapy; divalproex and lamotrigine also show potential augmenting roles.
• These medications are being investigated for at least 21 other conditions, based on preliminary data.

Conclusions:

• Lithium and lamotrigine offer antidepressant benefits in bipolar disorder, either alone or in combination therapy.
• The anticonvulsants divalproex and lamotrigine show promise as adjuncts to antidepressant treatments.
• Further controlled trials are warranted to validate the efficacy of these drugs for bipolar disorder and other conditions.